Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

HDMA CEO John Gray Starts In April, To Guide Group Through Industry Change

  • News

Executive Summary

John Gray will take over as CEO of the Healthcare Distribution Management Association in mid-April

You may also be interested in...



ABC Goes To D.C.: Former Amgen Exec Norton Will Head Government Affairs

AmerisourceBergen is opening a Washington, D.C. government affairs office led by former Amgen VP Rita Norton

Reimportation Coming In 2005, HDMA’s Gray Predicts

Healthcare Distribution Management Association CEO John Gray expects there will be a reimportation program in 2005 regardless of the outcome of the presidential election

ABC Goes To D.C.: Former Amgen Exec Norton Will Head Government Affairs

AmerisourceBergen is opening a Washington, D.C. government affairs office led by former Amgen VP Rita Norton

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Tags:
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS043524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By